152 related articles for article (PubMed ID: 27590167)
1. 2-Arylbenzo[b]furan derivatives as potent human lipoxygenase inhibitors.
Lang L; Dong N; Wu D; Yao X; Lu W; Zhang C; Ouyang P; Zhu J; Tang Y; Wang W; Li J; Huang J
J Enzyme Inhib Med Chem; 2016; 31(sup4):98-105. PubMed ID: 27590167
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant and lipoxygenase inhibitory activity of oligostilbenes from the leaf and stem of Vitis amurensis.
Ha do T; Kim H; Thuong PT; Ngoc TM; Lee I; Hung ND; Bae K
J Ethnopharmacol; 2009 Sep; 125(2):304-9. PubMed ID: 19560532
[TBL] [Abstract][Full Text] [Related]
3. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
Wisastra R; Ghizzoni M; Boltjes A; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2012 Aug; 20(16):5027-32. PubMed ID: 22789707
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of xanthine oxidase inhibitory and antioxidant activities of 2-arylbenzo[b]furan derivatives based on salvianolic acid C.
Tang HJ; Zhang XW; Yang L; Li W; Li JH; Wang JX; Chen J
Eur J Med Chem; 2016 Nov; 124():637-648. PubMed ID: 27614410
[TBL] [Abstract][Full Text] [Related]
5. Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
Detsi A; Majdalani M; Kontogiorgis CA; Hadjipavlou-Litina D; Kefalas P
Bioorg Med Chem; 2009 Dec; 17(23):8073-85. PubMed ID: 19853459
[TBL] [Abstract][Full Text] [Related]
6. Structural modifications of coumarin derivatives: Determination of antioxidant and lipoxygenase (LOX) inhibitory activity.
Roussaki M; Zelianaios K; Kavetsou E; Hamilakis S; Hadjipavlou-Litina D; Kontogiorgis C; Liargkova T; Detsi A
Bioorg Med Chem; 2014 Dec; 22(23):6586-6594. PubMed ID: 25456384
[TBL] [Abstract][Full Text] [Related]
7. Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1.
Eleftheriadis N; Thee S; te Biesebeek J; van der Wouden P; Baas BJ; Dekker FJ
Eur J Med Chem; 2015 Apr; 94():265-75. PubMed ID: 25771032
[TBL] [Abstract][Full Text] [Related]
8. Substituted furans as potent lipoxygenase inhibitors: Synthesis, in vitro and molecular docking studies.
Vinayagam J; Gajbhiye RL; Mandal L; Arumugam M; Achari A; Jaisankar P
Bioorg Chem; 2017 Apr; 71():97-101. PubMed ID: 28143657
[TBL] [Abstract][Full Text] [Related]
9. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids from the Bark of Artocarpus integer var. silvestris and their Anti-inflammatory Properties.
Shaha MKK; Sirata HM; Jamil S; Jalil J
Nat Prod Commun; 2016 Sep; 11(9):1275-1278. PubMed ID: 30807020
[TBL] [Abstract][Full Text] [Related]
11. Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.
Ducharme Y; Brideau C; Dubé D; Chan CC; Falgueyret JP; Gillard JW; Guay J; Hutchinson JH; McFarlane CS; Riendeau D
J Med Chem; 1994 Feb; 37(4):512-8. PubMed ID: 8120869
[TBL] [Abstract][Full Text] [Related]
12. Exploring the role of chloro and methyl substitutions in 2-phenylthiomethyl-benzoindole derivatives for 5-LOX enzyme inhibition.
Peduto A; Krauth V; Collarile S; Dehm F; Ambruosi M; Belardo C; Guida F; Massa A; Esposito V; Maione S; de Rosa M; Werz O; Filosa R
Eur J Med Chem; 2016 Jan; 108():466-475. PubMed ID: 26708113
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant activity and inhibition of α-glucosidase by hydroxyl-functionalized 2-arylbenzo[b]furans.
Hsieh JF; Lin WJ; Huang KF; Liao JH; Don MJ; Shen CC; Shiao YJ; Li WT
Eur J Med Chem; 2015 Mar; 93():443-51. PubMed ID: 25728025
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Evaluation of N-Aryl-5-aryloxazol-2-amine Derivatives as 5-Lipoxygenase Inhibitors.
Suh JH; Yum EK; Cho YS
Chem Pharm Bull (Tokyo); 2015; 63(8):573-8. PubMed ID: 26040270
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxyanthranilic acid derivatives as potent 5-lipoxygenase inhibitors.
Ohkuma H; Tomita K; Hoshino Y; Suzuki K; Hasegawa M; Sawada Y; Konishi M; Hook DJ; Oki T
J Antibiot (Tokyo); 1993 May; 46(5):705-11. PubMed ID: 8514624
[TBL] [Abstract][Full Text] [Related]
18. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.
Filali I; Belkacem MA; Ben Nejma A; Souchard JP; Ben Jannet H; Bouajila J
J Enzyme Inhib Med Chem; 2016; 31(sup1):23-33. PubMed ID: 27028352
[TBL] [Abstract][Full Text] [Related]
20. Novel lipoxygenase inhibitors, tetrapetalone B, C, and D from Streptomyces sp.
Komoda T; Kishi M; Abe N; Sugiyama Y; Hirota A
Biosci Biotechnol Biochem; 2004 Apr; 68(4):903-8. PubMed ID: 15118321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
